Rituximab treatment for dermatitis herpetiformis in the setting of type 1 diabetes mellitus, celiac disease, vitiligo, autoimmune hemolytic anemia, and autoimmune thrombocytopenia
- Resource Type
- article
- Source
- JAAD Case Reports, Vol 6, Iss 2, Pp 122-123 (2020)
- Subject
autoimmune hemolytic anemia dermatitis herpetiformis rituximab Dermatology RL1-803 - Language
- English
- ISSN
- 2352-5126